MAP4343

CAS : 511-26-2

Ref. 3D-AAA51126

Informations sur le produit

• Nom: MAP4343
• Synonymes: (3β)-3-Methoxypregn-5-en-20-one, 3β-Methoxy-5-pregnen-20-one, L 542856-0, Map 4343, NSC 31617, Pregn-5-en-20-one, 3-methoxy-, (3.beta.)-, Pregn-5-en-20-one, 3-methoxy-, (3β)-, Pregn-5-en-20-one, 3.beta.-methoxy-, Pregn-5-en-20-one, 3β-methoxy-, Pregnenolone 3-methyl ether, Pregnenolone methyl ether
• CAS: 511-26-2

Description

MAP4343 is a peptide that has been shown to activate the ERK1/2 and JNK pathways. MAP4343 has also been shown to bind to the TGF-β receptor, which is a receptor tyrosine kinase that regulates cell proliferation, differentiation, and apoptosis. The ligand for this receptor is Transforming Growth Factor beta 1 (TGF-β1). MAP4343 can be used as a research tool for studying protein interactions and receptors.
MAP4343 is an inhibitor of Ion channels, such as voltage-gated potassium channels. It can inhibit ion channel currents in Xenopus oocytes expressing human potassium channels by binding to the extracellular domain of these channels. This inhibition leads to a decrease in the membrane potential.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 330.5 g/mol
• Formule: C₂₂H₃₄O₂
• Degré de pureté: Min. 95%